Cargando…
Aberrant expression of NEK2 and its clinical significance in non-small cell lung cancer
The purpose of the present study was to identify a potential biomarker that is more effective than those already available for the prognosis of non-small cell lung cancer (NSCLC) patients. The expression of never in mitosis gene A (NIMA)-related kinase 2 (NEK2), minichromosome maintenance complex co...
Autores principales: | ZHONG, XINWEN, GUAN, XIAOJIAO, LIU, WENKE, ZHANG, LIN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4156209/ https://www.ncbi.nlm.nih.gov/pubmed/25202351 http://dx.doi.org/10.3892/ol.2014.2396 |
Ejemplares similares
-
Aberrant expression of HIF3A in plasma of patients with non‐small cell lung cancer and its clinical significance
por: Wei, Liang, et al.
Publicado: (2021) -
Analysis of the effect of NEKs on the prognosis of patients with non-small-cell lung carcinoma based on bioinformatics
por: Yang, Mengxia, et al.
Publicado: (2022) -
Ectopic expression of LAG‐3 in non–small‐cell lung cancer cells and its clinical significance
por: Ma, Chenglong, et al.
Publicado: (2020) -
NEK2 plays an active role in Tumorigenesis and Tumor Microenvironment in Non-Small Cell Lung Cancer
por: Bai, Rui, et al.
Publicado: (2021) -
Aberrant expression of ADAM9 in ovarian cancer and its clinical significance
por: Guo, Ting, et al.
Publicado: (2019)